Asthma Therapeutics Global Market Report 2026

Description

Asthma therapeutics encompass the range of medications and treatment options used to control and alleviate asthma symptoms, a chronic respiratory disorder marked by airway inflammation and narrowing. These therapies include rapid-acting medicines for immediate symptom relief as well as long-term control treatments that help reduce airway inflammation and prevent asthma exacerbations.

The main drug classes included in asthma therapeutics are inhaled corticosteroids (ICS), long-acting beta agonists, leukotriene receptor antagonists, short-acting beta agonists, biologics, and combination inhalers. Inhaled corticosteroids are medications delivered directly to the lungs to decrease inflammation and swelling in the airways, making breathing easier for individuals with asthma. They are used across different stages of treatment, including acute care, long-term control, preventive therapy, maintenance regimens, and rescue treatment, and are administered through various routes such as oral, inhaled, intravenous, and subcutaneous. These therapies are distributed through channels including hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized by end users such as hospitals, home care settings, and specialty clinics.

Tariffs have influenced the asthma therapeutics market by increasing the cost of imported active pharmaceutical ingredients (APIs) and inhaler devices. Segments such as biologics, combination inhalers, and specialty medications are particularly affected, with regions like North America and Europe facing higher import duties. These tariffs have led to increased treatment costs and adjustments in supply chains. On the positive side, they are encouraging local manufacturing, innovation in delivery systems, and investment in domestic pharmaceutical production capabilities.

The asthma therapeutics market research report is one of a series of new reports from The Business Research Company that provides asthma therapeutics market statistics, including asthma therapeutics industry global market size, regional shares, competitors with a asthma therapeutics market share, detailed asthma therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the asthma therapeutics industry. This asthma therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The asthma therapeutics market size has grown strongly in recent years. It will grow from $33.11 billion in 2025 to $35.73 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited availability of biologics, reliance on short-acting beta agonists, rising prevalence of asthma globally, increasing hospital and specialty clinic visits, adoption of oral and inhaled medications.

The asthma therapeutics market size is expected to see strong growth in the next few years. It will grow to $47.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to development of novel biologics and combination therapies, expansion of telemedicine and digital health monitoring, growing preventive treatment awareness, increasing healthcare access in emerging markets, rising investment in research and drug development. Major trends in the forecast period include rising adoption of personalized asthma therapies, increase in inhaler and biologic usage, expansion of homecare and remote monitoring solutions, growing preference for combination inhalers, enhanced focus on pediatric and geriatric asthma care.

The rising prevalence of asthma is anticipated to drive the growth of the asthma therapeutics market in the coming years. Asthma is a chronic condition characterized by inflammation and swelling of the airways, leading to narrowing of the passages that carry air from the nose and mouth to the lungs. The increasing incidence of asthma is largely attributed to rising levels of air pollution, which irritate the airways and increase the likelihood of developing the disease. Asthma therapeutics play a vital role in managing the condition by reducing airway inflammation, alleviating symptoms, and preventing asthma attacks. For instance, in May 2025, according to the UK Parliament, a UK-based government body, 3,886,879 individuals aged six and above were diagnosed with asthma in England during 2023-24, representing 6.5% of the population. Therefore, the growing prevalence of asthma is contributing to the expansion of the asthma therapeutics market.

Major companies operating in the asthma therapeutics market are concentrating on the development of innovative treatments, such as anti-inflammatory rescue inhalers, to improve symptom control, reduce inflammation, and enhance overall disease management. Anti-inflammatory rescue inhalers use a dual-action approach that combines a fast-acting bronchodilator with an inhaled corticosteroid in a single device, enabling rapid airway relaxation, on-demand inflammation control, and prevention of severe asthma exacerbations. For instance, in January 2024, AstraZeneca plc, a UK-based biopharmaceutical company, introduced AIRSUPRA, an FDA-approved anti-inflammatory rescue inhaler designed to provide immediate symptom relief along with rapid anti-inflammatory effects. The inhaler features as-needed dual-mechanism dosing, real-time suppression of airway inflammation, and support in reducing exacerbation-related declines in lung function. AIRSUPRA improves asthma control, lowers the risk of severe attacks, and enhances the effectiveness of rescue therapy.

In January 2025, Phillips Medisize, a US-based contract development and manufacturing organization (CDMO), acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Phillips Medisize aims to strengthen its inhalation drug delivery capabilities by incorporating Vectura's extensive expertise in formulation and device development across dry powder inhalers, nebulizers, metered-dose inhalers, and nasal delivery systems. Vectura Group Ltd. is a UK-based company specializing in inhalation formulation, device engineering, and regulatory support services.

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.

North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the asthma therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The asthma therapeutics market consists of revenues earned by entities by providing services such as prescription management, inhaler technique training, nebulization therapy, and allergy testing and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma therapeutics market consists of sales of methylxanthines, anticholinergics, systemic corticosteroids, mast cell stabilizers, immunotherapy products, and adjunctive therapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Asthma Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses asthma therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for asthma therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The asthma therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Drug Class: Inhaled Corticosteroids (ICS); Long-Acting Beta Agonists (LABA); Leukotriene Receptor Antagonists (LTRA); Short-Acting Beta Agonists (SABA); Biologics; Combination Inhalers (ICS + LABA)
2) By Treatment Stage: Acute Treatment; Long-Term Control; Preventive Treatment; Maintenance Regimens; Rescue Medications
3) By Route Of administration: Oral; Inhaled; Intravenous; Subcutaneous
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End-User: Hospitals; Homecare; Specialty Clinics
Subsegments:
1) By Inhaled Corticosteroids (ICS): Fluticasone; Budesonide; Beclomethasone; Mometasone; Ciclesonide
2) By Long-Acting Beta Agonists (LABA): Salmeterol; Formoterol; Indacaterol; Olodaterol
3) By Leukotriene Receptor Antagonists (LTRA): Montelukast; Zafirlukast; Pranlukast
4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol); Levalbuterol; Terbutaline
5) By Biologics: Omalizumab; Mepolizumab; Benralizumab; Dupilumab; Reslizumab
6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol; Budesonide + Formoterol; Mometasone + Indacaterol; Beclomethasone + Formoterol
Companies Mentioned: Roche Holding AG; Merck & Co Inc.; Pfizer Inc.; AstraZeneca plc; Sanofi S.A.; Novartis AG; GlaxoSmithKline plc; Boehringer Ingelheim GmbH; Teva Pharmaceutical Industries Ltd.; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Ltd.; Chiesi Farmaceutici S.p.A.; Cipla Limited; Mylan N.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH5MATHE03_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Asthma Therapeutics Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Asthma Therapeutics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Asthma Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Asthma Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Rising Adoption Of Personalized Asthma Therapies
- 4.2.2 Increase In Inhaler And Biologic Usage
- 4.2.3 Expansion Of Homecare And Remote Monitoring Solutions
- 4.2.4 Growing Preference For Combination Inhalers
- 4.2.5 Enhanced Focus On Pediatric And Geriatric Asthma Care

5. Asthma Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Homecare Patients
5.3 Specialty Clinics
5.4 Pharmacies
5.5 Research Institutions

6. Asthma Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Asthma Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Asthma Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Asthma Therapeutics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Asthma Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Asthma Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Asthma Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Asthma Therapeutics Market Segmentation

9.1. Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)
9.2. Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications
9.3. Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Inhaled, Intravenous, Subcutaneous
9.4. Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
9.5. Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare, Specialty Clinics
9.6. Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide
9.7. Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Salmeterol, Formoterol, Indacaterol, Olodaterol
9.8. Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Montelukast, Zafirlukast, Pranlukast
9.9. Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Albuterol (Salbutamol), Levalbuterol, Terbutaline
9.10. Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab
9.11. Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

10. Asthma Therapeutics Market Regional And Country Analysis

10.1. Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Asthma Therapeutics Market

11.1. Asia-Pacific Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Asthma Therapeutics Market

12.1. China Asthma Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Asthma Therapeutics Market

13.1. India Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Asthma Therapeutics Market

14.1. Japan Asthma Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Asthma Therapeutics Market

15.1. Australia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Asthma Therapeutics Market

16.1. Indonesia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Asthma Therapeutics Market

17.1. South Korea Asthma Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Asthma Therapeutics Market

18.1. Taiwan Asthma Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Asthma Therapeutics Market

19.1. South East Asia Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Asthma Therapeutics Market

20.1. Western Europe Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Asthma Therapeutics Market

21.1. UK Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Asthma Therapeutics Market

22.1. Germany Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Asthma Therapeutics Market

23.1. France Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Asthma Therapeutics Market

24.1. Italy Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Asthma Therapeutics Market

25.1. Spain Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Asthma Therapeutics Market

26.1. Eastern Europe Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Asthma Therapeutics Market

27.1. Russia Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Asthma Therapeutics Market

28.1. North America Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Asthma Therapeutics Market

29.1. USA Asthma Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Asthma Therapeutics Market

30.1. Canada Asthma Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Asthma Therapeutics Market

31.1. South America Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Asthma Therapeutics Market

32.1. Brazil Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Asthma Therapeutics Market

33.1. Middle East Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Asthma Therapeutics Market

34.1. Africa Asthma Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Asthma Therapeutics Market, Segmentation By Drug Class, Segmentation By Treatment Stage, Segmentation By Route Of administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Asthma Therapeutics Market Regulatory and Investment Landscape

36. Asthma Therapeutics Market Competitive Landscape And Company Profiles

36.1. Asthma Therapeutics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Asthma Therapeutics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Asthma Therapeutics Market Company Profiles
- 36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Asthma Therapeutics Market Other Major And Innovative Companies

Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V

38. Global Asthma Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Asthma Therapeutics Market

40. Asthma Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Asthma Therapeutics Market In 2030 - Countries Offering Most New Opportunities
40.2 Asthma Therapeutics Market In 2030 - Segments Offering Most New Opportunities
40.3 Asthma Therapeutics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer